连续7份财报“失真”！城地香江收上海证监局警示函 3名前高管同步被追责

Core Viewpoint - Chengdi Xiangjiang has received an administrative regulatory measure decision from the Shanghai Securities Regulatory Bureau due to inaccurate financial report data disclosures for multiple reporting periods [2][8]. Financial Reporting Issues - The company has been found to have three major categories of accounting errors affecting seven financial reports, including the consolidated balance sheet and income statement [5]. - The first category involves internal transaction offsetting errors, leading to understated operating costs and overstated inventory and revenue [5]. - The second category pertains to misclassification of amortization of right-of-use assets, resulting in distorted data in several financial statement categories [5]. - The third category includes delayed revenue recognition for five specific projects, impacting reported operating income and retained earnings [6]. Regulatory Actions - Chengdi Xiangjiang and its former chairman, Xie Xiaodong, have been issued warning letters by the Shanghai Securities Regulatory Bureau [3][8]. - The regulatory body has indicated that the accounting errors led to inaccuracies in the 2023 interim report, annual report, and 2024 interim report, violating relevant regulations [8]. - The company and responsible individuals have the right to appeal the regulatory measures within specified timeframes [8]. Company Response - Chengdi Xiangjiang has acknowledged the issues and stated that all board members and senior management will enhance regulatory compliance and internal control systems to prevent recurrence [8]. - The company emphasized that the administrative regulatory measures do not have a significant impact on its operations [8].